BioNTech, Pfizer's German partner on its COVID-19 vaccine, says that the pair of companies are committed to delivering all 1.8 billion doses of vaccines in their order backlog, BioNTech said Monday. The German firm added that there is no evidence the Covid vaccine made by Pfizer and partner BioNTech needs updating to protect against variants. However, the company said it had developed a 'comprehensive strategy' to address any coronavirus variants in the future should the need arise. A deal for another 20 million doses of Pfizer's vaccine was signed by South Africa last month. Pfizer and BioNTech also began their application for full Food and Drug Administration (FDA) approval last week, which would make it the first fully approved shot.

Source: Daily Mail May 10, 2021 15:47 UTC